The NIH RECOVER Long-COVID Clinical Trials are Set to Fail: Here’s What Should be Trialed Instead
The RECOVER Initiative focused on low risk low reward clinical trials for long COVID. Here are some possibilities that could have made a real difference. .
Flo Stops the Leaks in Her Boat at Last: Her Long ME/CFS/FM Recovery Story
Flo's long, long battle with fibromyalgia and chronic fatigue syndrome (ME/CFS) brought her to despair but her turnaround was just around the corner. Found out she recovered.
Triple Antiviral Coronavirus/Herpesvirus Approach Scores in Very Early Long COVID Testing
A triple antiviral drug combination attacking both the coronaviruses and herpesviruses in long COVID score some impressive results in a very early trial.
Dr. Pridgen and his Antivirals Take on Long COVID as his Fibromyalgia Effort Nears its Endgame
Dr. Pridgen's duo antiviral drug trial for long COVID produces promising results.
A Moonshot For ME/CFS, Knocking EBV Down and a Stuck Long-COVID Study: The 2023 INIM Conference Highlights
Mary Anne Fletcher (1937-2023) – In Memoriam I only met Mary Anne a few times, but they were vivid. I remember – years ago – watching with a little awe as she boldly and vociferously called for NIH-funded treatment trials for ME/CFS. She...Lives Interrupted Latest Story
Bob Graybosch
Lahaina, United States
Former occupation: Resort General Manager
$1,261,443
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
